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ORIGINAL ARTICLE
Psychotropic treatment in patients undergoing 
gynaecological procedures 
Bertha Grech, Yves Muscat Baron 
BACKGROUND 
Around 27% of the adult population in Europe has at some point 
suffered from a mental disorder in the past year.  Patients with 
psychiatric illness have different needs and require specific 
medication review prior to surgery in view of the risks from 
anesthesia, the direct and indirect effects of psychotropics, risk of 
withdrawal symptoms, and risk of psychiatric recurrence or relapse. 
Gynaecological patients, particularly those going through the 
menopausal transition phase have an associated risk of psychiatric 
conditions especially mood disorders.  
This audit is set to determine the link between psychotropic drug use 
in patients seen at gynaecological pre-operative assessment clinic 
(POAC), the most encountered diagnosis, how this relates to age 
together with analysis of most common drugs used to treat these 
patients.  
METHODS 
Data about 123 patients from 24 weekly POAC was collected. The 
number of patients listed in each clinic was documented together 
with the patient’s age. Patients on psychotropic medication were 
analysed to note diagnoses of each case and treatment used. 
RESULTS 
21.1% of patients suffered from a mental health illness requiring 
psychotropic medication.  Their average age was that of 51 years. The 
most common diagnosis was depression, summing up to 9.8% of all 
patients, followed by anxiety at 6.5%. 
CONCLUSION 
Depression and anxiety are leading mental health illnesses both in 
this cohort and the general population. Such patients have lower pain 
threshold which affects their recovery. Some psychotropics have 
severe interactions with anaesthetic thus need to be stopped prior 
to surgery after evaluation of risks such as drug withdrawal and 
deterioration in mental health. 
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INTRODUCTION 
Around 27% of the adult population in Europe 
has at some point suffered from a mental 
disorder in the past year. Such psychiatric 
conditions include psychotic disorders, 
anxiety, depression, substance abuse and 
eating disorders.1 
Neuropsychiatric disorders in Europe 
accumulate to 15.2% of disability-adjusted life 
years (DALYs), thus being the 3rd most 
common cause, followed by cardiovascular 
diseases accounting for 26.6% and malignant 
neoplasms accounting for 15.4%.2 
Overall females have significantly higher rates  
of mental health disorders when compared to 
males (except for substance use and psychotic 
illness). The female gender is a significant 
predictor of the need for prescription of mood 
altering psychotropic drugs. In the older 
population depression, organic brain 
syndromes and dementias are the leading 
mental health problems, with higher 
prevalence in females.2 
Gynaecological patients, particularly those 
going through the menopausal transition 
phase have an associated risk of psychiatric 
conditions especially mood disorders. Several 
longitudinal studies revealed that females in 
the menopause transition are up to twice as 
likely to experience a depressive disorder, 
compared to the premenopausal period, 
independent of a history of depression.3 
This audit is set to determine the link between 
psychotropic drug use and patients seen at 
gynaecological pre-operative assessment 
clinic (POAC), the most encountered diagnosis, 
how this relates to age together with analysis 
of most common drugs used to treat these 
patients.  
 
MATERIALS AND METHODS 
The study was conducted at Mater Dei 
Hospital, Malta and approved by both the local 
audit committee and by the data protection 
management. Data from 24 weekly POAC of a 
gynaecological firm was collected. This 
accumulated to 6 months of POAC held, from 
September 2018 till February 2019. The total 
number of patients listed in each clinic was 
documented together with the patient’s age. 
Patients who were on psychotropic medication 
were analysed further to note diagnoses of 
each case and what type of treatment was 
being given. 
RESULTS 
Out of a total of 123 patients who attended 
one of the 24 POACs analysed for this study, 26 
were suffering from at least one psychiatric 
condition requiring use of psychotropic 
medication, representing a total of 21.1% of 
the patients seen.  
The age range of patient attending this clinic 
was between 19 to 83 years of age. The 
average age of the patients was 48 years, 
whilst the average age of the patients on 
psychotropic treatment was that of 51years. 
The most common diagnosis in this cohort of 
patients was mood disorder, specifically, 
depressive disorder of varied severity. In total 
12 patients were at some point diagnosed with 
depression, that is 9.8% of all patients seen in 
clinic during the 6 months being analysed. 
Depression was the diagnoses in 46.2% of the 
patients having a form of psychiatric disorder. 
The second most common diagnosis was 
anxiety disorder, a total of 8 patients (6.5% of 
all patient seen and 31.9% of patients with a 
psychiatric diagnosis). Other diagnoses 
encountered during the analysis include; sleep 
disorders, developmental disorders 
(particularly attention deficit and hyperactivity 
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disorder, seen predominantly in the younger 
patients), psychosis and schizophrenia. The 
number of each case and their equivalent 
percentage of the total can be noted in the 
table below (table 1). Three of the patients 
seen, 11.5% (of psychiatric patient), reported 
more than one psychiatric condition.  
The age groups of patients with mental health 
illness revealed that the majority of patients 
were post menopausal, the most common age 
group being that between 61 and 80 years of 
age. The second most common subgroup was 
females between the ages of 21 and 40 years. 
Other age groups and the percentage of 
patients in each can be noted in the table 
below (table 2). 
Treatment analysis revealed that half of the 
psychiatric patients were prescribed 
monotherapy whilst the other half was making 
use of more than one psychotropic drug. The 
most common drug class prescribed was an 
antidepressant, 19 patients meaning 73.1% of 
psychiatric patients were on antidepressants, 
particularly  selective serotonin reuptake 
inhibitor (SSRI) followed by serotonin–
norepinephrine reuptake inhibitor (SNRI) and 
tricyclic antidepressant (TCA) (table 3). 
Antipsychotics were the second most common 
prescribed drug of choice in this cohort, 
atypical being more common than typical 
antipsychotics (8 versus 5 patients of the total) 
followed by benzodiazepines, antihistamines 
and mood stabilizers (table 4). 
 
 
Diagnoses 
Number of patients 
(from a total of 
123) 
Percentage from 
total psychiatric 
cases 
Percentage from 
total of patients 
seen 
Mood disorders 12 46.2% 9.8% 
Anxiety disorder 8 31.9% 6.5% 
Psychosis/ 
Schizophrenia 
4 15.4% 3.25% 
Sleep disorder 3 11.5% 2.45% 
Developmental 
disorder 
2 7.7% 1.63% 
 
 
 
 
Table 1   Numbers of patient with different psychiatric diagnosis 
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Age group 
Number of patients (from a total 
of 123) 
Percentage from total psychiatric 
patients 
<20 2 7.7% 
21-40 6 23.1% 
41-60 5 19.3% 
61-80 12 46.2% 
>81 1 3.8% 
 
 
 
Class of 
antidepressant 
Number of patients  (from a 
total of 123) 
Percentage from total patient on 
psychotropic treatment 
SSRI 16 61.5% 
SNRI 2 7.7% 
TCA 1 3.8% 
 
 
 
Drug class 
Number of patients (from a 
total of 123) 
Percentage from total patient on 
psychotropic treatment 
Antipsychotics 13 50% 
Benzodiazepines 6 23.1% 
Antihistamines 6 23.1% 
Mood stabilizers 3 11.5% 
 
 
 
 
Table 2   Ages of patients with psychiatric condition 
Table 3   Number of patients on different classes of antidepressants 
Table 4   Number of patient on other psychotropic drugs 
39
Malta Medical Journal     Volume 32 Issue 01 2020           
 
DISCUSSION 
Out of a total of 123 patients, 26 patients were 
suffering from at least one psychiatric 
condition requiring use of psychotropic 
medication, representing a total of 21.1% of 
the patients seen.  
Depression is the most common mental health 
disorder encountered in this particular cohort 
of patients representing a total of 9.8% of 123 
patients seen over 6 months. Mood disorder is 
followed by anxiety disorder at a rate of 6.5%. 
These numbers reflect general prevalence 
rates where 7.8% of the population is known 
to suffer from anxiety and depression, these 
being the most common mental health illness.4 
Symptoms of anxiety include feeling worried, 
fearful, irritability, breathlessness, 
hyperventilation, palpitations, gastrointestinal 
disturbances, trembling and palpitations. 
Symptoms of depression on the other hand 
include low mood, anhedonia, anergia, feeling 
of hopelessness, guilt, low self worth, inability 
to maintain concentration, changes in appetite 
and sleeping difficulties.  
Certain links have been made between 
hormonal fluctuations and an increase in 
prevalence of depression in women 
particularly during the phases of puberty, prior 
to menstruation, during the postnatal period 
and in perimenopause, suggesting that 
hormone changes might be triggers for 
depressive symptoms.5 Further studies 
however have found no well based correlation 
between hormonal changes, mainly the falling 
and fluctuating levels of estradiol and 
corresponding increases in levels of follicle‐
stimulating hormone (FSH) and luteinizing 
hormone. Thus, at present, the literature 
indicates no consistent relationship between 
circulating estradiol/FSH levels and 
depression.6 
As previously noted, females in the 
menopause transition are up to twice as likely 
to experience a depressive disorder, compared 
to the premenopausal period, independent of 
a history of depression.3 Low mood, sleep 
disturbance and low libido, are possible 
symptoms of depression but also happen to be 
common experiences of menopause 
independent of mood disturbance. Such a 
phenomenon is clinically significant for both 
management decisions and monitoring of 
response to treatment. Furthermore, this 
highlights the broad nature of menopausal 
symptoms and the potential clinical value in 
creating menopause-specific tools for mental 
health.  
With regards to treatment, SSRIs were found 
to be the most commonly prescribed drugs 
amongst patients on regular psychotropic 
medication. SSRIs are in fact the first line 
treatment option when it comes to medication 
use in cases of depression and anxiety. TCAs 
are less used and one should keep in mind that 
this class of drugs carries a higher chance of 
overdose which could be dangerous in patient 
with risk of suicide. Some side effects of these 
SSRIs worth mentioning are headache, dry 
mouth, dizziness, insomnia, sexual 
dysfunction, nausea and weight changes. 
Metabolically, SSRIs do not tend to 
dysregulate glycaemic control as opposed to 
TCAs which have been found to cause 
deterioration in the metabolic situation of the 
patient.7 
These patients being seen at preoperative 
clinic in preparation for surgery under general 
anaesthesia would need medication review. 
Some psychotropic drugs such as lithium, 
monoamine oxidase inhibitors, TCAs, and 
clozapine interact with certain types of 
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anesthesia; thus it is important to highlight 
their use to an anesthetist. These psychotropic 
drugs present with increased physical risks, 
including withdrawal symptoms, thus 
qualifying for American Society of 
Anesthesiologists Classification 3. On the basis 
of physical risks, they would require 
discontinuation however from the perspective 
of the risk of withdrawal together with 
psychiatric relapse and recurrence, these 
individuals deserve integrated management 
from both anaesthetist and psychiatrist. Some 
interactions of note include, TCAs causing an 
increased response to anticholinergics such as 
atropine which may lead to postoperative 
confusion. Serious side-effect have been 
reported in 21% of patients receiving 
antipsychotic treatment, these include extra-
pyramidal symptoms such as sedation or 
hypotension.8 
Mood stabilisers such as lithium, used in 
bipolar disorder, may cause hazardous risks in 
surgery. This is mostly seen when 
haemodynamic instability occurs and renal 
excretion becomes impeded. Therefore, 
lithium discontinuation is recommended 
before surgery. Lithium can be stopped at 
once because no withdrawal symptoms occur 
and thus should be discontinued 72 h before 
surgery since it has a half-life of 24–36 hours. 
Sodium depletion decreases renal excretion of 
lithium and can lead to lithium toxicity. 
Prevention of excess absorption of lithium can 
be prevented pre-emptively via the 
administration of sodium-containing IV fluids 
during the peri-operative period. ECG 
monitoring should be done to monitor various 
cardiac abnormalities due to lithium. In the 
post-operative period, once normal ranges of 
potassium, sodium and creatinine are 
obtained, and the patient is considered 
haemodynamically stable, she should be able 
and allowed to drink, and lithium should be 
restarted. This is most important because the 
psychiatric risk of recurrence or relapse is 
hazardous. The only reason not to stop lithium 
is minor surgery with local anaesthesia.8 
The implications of outcome of psychiatric 
versus non psychiatric patients, mainly 
patients suffering from depression include; 
lower pain threshold, higher pain sensitivity 
and increased self reported pain intensity.9 
Furthermore, patients with depressive 
disorder were found to have associated pain 
and self reported anxiety symptoms. This can 
affect the postoperative state of the patient 
possibly resulting in the need for additional 
analgesia and prolonged hospital stay which 
can in itself place the patient at increased risk 
of hospital acquired infections, decline in 
independence with self care and risks from 
immobility as deep vein thrombosis and 
pressure sores. In cases of patient suffering 
from anxiety one might note an increase in 
patients’ need for information about the 
procedure and to a certain extent demands of 
reassurance. In such instances the person 
obtaining consent for the surgery should be 
familiar with the procedure, risks and 
complications rates to give the patient clear 
details and offer reassurance when possible.  
The limitations of this audit include the fact 
that the sample included only the patients 
seen over six months and that the cohort was 
limited to those seen by one specific 
consultant. One can also mention that some 
patients might have been in disease remission 
and not on active treatment when seen at 
POAC and thus not included in the number of 
patient suffering from mental health illnesses.  
CONCLUSION 
Out of a total of 123 patients who attend one 
of the 24 pre-operative assessment clinics 
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analysed for this study, 26 were suffering from 
at least one psychiatric condition requiring use 
of psychotropic medication, representing a 
total of 21.1% patients. Depression is the most 
common mental health disorder encountered 
in this particular cohort of patients 
representing a total of 9.8% of 123 patients 
and 46.2% of the mental health diagnoses 
seen in this particular clinic. The second most 
common reported diagnosis was anxiety 
disorder, representing 6.5% of all patients 
seen and 31.9% of the patients with a 
psychiatric diagnosis. The most common drug 
class prescribed was an antidepressant, 19 
patients, meaning 73.1% of psychiatric 
patients were on antidepressants, most 
commonly an SSRI. 
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